Takeda Pharmaceutical (TAK) EPS (Diluted) (2017 - 2026)
Powered by 
Analysis
Takeda Pharmaceutical (TAK) EPS (Diluted) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | -3.06 |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 7.27 |
| 10 | Takeda Pharmaceutical | 2.61 Bn | -3.18 Bn | 5.10 Bn | 4.96 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.96 |
| Mar 31, 2026 | 5.53 |
| Dec 31, 2025 | -16.41 |
| Sep 30, 2025 | 10.05 |
| Jun 30, 2025 | 5.88 |
| Mar 31, 2025 | 5.58 |
| Dec 31, 2024 | -4.72 |
| Sep 30, 2024 | 9.85 |
| Jun 30, 2024 | 4.26 |
| Mar 31, 2024 | 4.47 |
| Dec 31, 2023 | 1.47 |
| Sep 30, 2023 | 13.87 |
| Jun 30, 2023 | 4.57 |
| Mar 31, 2023 | 5.56 |
| Dec 31, 2022 | 5.88 |
| Sep 30, 2022 | 3.12 |
| Jun 30, 2022 | 5.66 |
| Mar 31, 2022 | -0.68 |
| Dec 31, 2021 | 8.05 |
| Sep 30, 2021 | 2.92 |